Answers are grounded in this paper and cite their sources.
Nirmatrelvir is a potent, selective, and orally bioavailable inhibitor of SARS-CoV-2 M pro . In this paper, we report the development of a magnesium sulfate (MgSO 4 )-mediated aminolysis for the synthesis of ( S )-2-amino-3-[( S )-2-oxopyrrolidin-3-yl]propenamide hydrogen chloride, the eastern fragment of nirmatrelvir. Previous synthesis of this building block required a protecting group, high equivalents of ammonia, and a long reaction time and generated materials with moderate potency and high levels of residual solvents. We determined that MgSO 4, a widely available and low-cost material, accelerates the desired aminolysis reaction and suppresses the formation of impurities without the need for high equivalents of ammonia or a protecting group. Our understanding of the solubility profile of this intermediate facilitated the development of a robust isolation protocol to purge byproducts and generate high-potency materials regardless of the source of the precursors. The MgSO 4 -mediated aminolysis process was demonstrated to produce >350 kg of the building block per batch.
No takes yet. Share an insight, caveat, or question.
Algera et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: